Nodopathies of the peripheral nerve: An emerging concept

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 11, 2015, Pages 1186-1195

  Uncini, Antonino ^a   Kuwabara, Satoshi ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; SODIUM CHANNEL; WATER;

ACUTE MOTOR AXONAL NEUROPATHY; BERIBERI NEUROPATHY; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FLUID BALANCE; HUMAN; ISCHEMIC NEUROPATHY; MOTOR NEUROPATHY; NERVE CELL EXCITABILITY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FIBER MEMBRANE; NERVE POTENTIAL; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE NODOPATHY; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; MYELIN SHEATH; NERVE DEGENERATION; PATHOLOGY;

HUMANS; MYELIN SHEATH; NERVE DEGENERATION; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84947030061     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-310097     Document Type: Review

References (73)

1. Ranvier L. Contributions à l'histologie et à la physiologie des nerfs périphériques. Comptes Rendus de l'Académie des Sciences 1871;73:1168-71.
2. Huxley AF, Stämpfli R. Evidence for saltatory conduction in peripheral myelinated nerve fibers. J Physiol 1949;108:315-39.
3. Uncini A, Susuki K, Yuki N. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 2013;124:1928-34.
4. Susuki K. Node of Ranvier disruption as a cause of neurological diseases. ASN Neuro 2013;5:209-19.
5. Waxman SG, Ritchie JM. Molecular dissection of the myelinated axon. Ann Neurol 1993;33:121-36.
6. Caldwell JH, Shaller KL, Lasher RS, et al. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci USA 2000;97:5616-20.
7. Gutman GA, Chandy KG, Grissmer S, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005;57:473-508.
8. Reid G, Scholz A, Bostock H, et al. Human axons contain at least five types of voltage-dependent potassium channel. J Physiol 1999;518:681-96.
9. 2+-mediated injury in myelinated CNS axons. Brain Res 1994;644:197-204.
10. Rasband MN. Composition, assembly, and maintenance of excitable membrane domains in myelinated axons. Semin Cell Dev Biol 2011;22:178-84.
11. Gong Y, Tagawa Y, Lunn MP, et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 2002;125:2491-506.
12. Susuki K, Baba H, Tohyama K, et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 2007;55:746-57.
13. Koles ZJ, Rasminsky MA. Computer simulation of conduction in demyelinated nerve fibres. J Physiol 1972;227:351-64.
14. Sumner AJ, Saida K, Saida T, et al. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol 1982;11:469-77.
15. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol 1978;280:273-301.
16. Smith KJ, Bostock H, Hall SM. Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J Neurol Sci 1982;54:13-31.
17. Saida K, Sumner AJ, Saida T, et al. Antiserum mediated demyelination: relationship between remyelination and functional recovery. Ann Neurol 1980;8:12-24.
18. Zhang CL, Ho PL, Kintner DB, et al. Activity dependent regulation of mitochondrial motility by calcium and Na/K-ATPase at nodes of Ranvier of myelinated nerves. J Neurosci 2010;30:3555-66.
19. Vosler PS, Brennan CS, Chen J. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 2008;38:78-100.
20. Ma M, Ferguson TA, Schoch KM, et al. Calpains mediates axonal cytoskeleton disintegration during Wallerian degeneration. Neurobiol Dis 2013;56:34-46.
21. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487-95.
22. Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-8.
23. Capasso M, Caporale CM, Pomilio F, et al. Acute motor conduction block neuropathy. Another Guillain-Barré syndrome variant. Neurology 2003;61:617-22.
24. Yokota T, Saito Y, Miyatake T. Conduction slowing without conduction block of compound and nerve action potentials due to sodium channel block. J Neurol Sci 1994;124:220-4.
25. Kiernan MC, Burke D, Bostock H. Nerve excitability measures: biophysical basis and use in the investigation of peripheral nerve disease. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia: Elsevier Saunders, 2005:113-29.
26. Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66.
27. Sharizaila N, Kokubun N, Sawai S, et al. The relationship between Guillain-Barré syndrome subtypes and antibodies to ganglioside complexes. Neurology 2014;83:118-24.
28. Kuwabara S, Bostock H, Ogawara K, et al. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome. Muscle Nerve 2003;28:683-9.
29. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of Guillain-Barré syndrome. J Neurocytol 1996;25:33-51.
30. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-44.
31. Susuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-67.
32. McGonigal R, Rowan EG, Greenshields KN, et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 2010;133:1944-60.
33. Kokubun N, Nishibayashi M, Uncini A, et al. Conduction block in acute motor axonal neuropathy. Brain 2010;133:2897-908.
34. Uncini A, Manzoli C, Notturno F, et al. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-63.
35. Sekiguchi Y, Uncini A, Yuki N, et al. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012;83:23-8.
36. Vlam L, van der Pol WL, Cats EA, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol 2011;8:48-58.
37. Van Asseldonk JT, Van den Berg LH, Kalmijn S, et al. Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2006;77:743-7.
38. Kaji R, Oka N, Tsuji T, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-8.
39. Taylor BV Dyck PJ, Engelstad J, et al. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 2004;63:129-37.
40. Uncini A, Santoro M, Corbo M, et al. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993;16:610-15.
41. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-42.
42. Notturno F, Di Febo T, Yuki N, et al. Autoantibodies to Neurofascin 186 and gliomedin in multifocal motor neuropathy. J Neuroimmunol 2014;276:207-12.
43. Kiernan MC, Guglielmi JM, Kaji R, et al. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002;125:664-75.
44. Straver DC, Van Asseldonk JT, Notermans NC. Cold paresis in multifocal motor neuropathy. J Neurol 2011;258:212-7.
45. Franssen H, Gebbink TA, Wokke JH. Is cold paresis related to axonal depolarization? J Peripher Nerv Syst 2010;15:227-37.
46. Capasso M, Notturno F, Manzoli C, et al. Involvement of sensory fibers in axonal subtypes of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2011;82:664-70.
47. Capasso M, Notturno F, Manzoli C, et al. Reversible conduction failure in pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Muscle Nerve 2010;42:608-12.
48. Notturno F, Caporale CM, Uncini A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 2008;37:265-8.
49. Umapathi T, Tan EY, Kokubun N, et al. Non demyelinating reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012;83:941-8.
50. Miller JAL, Spyropoulos A, Jaros E, et al. Anti-GQ1b ganglioside positive Miller Fisher syndrome-evidence of paranodal pathology on nerve biopsy. J Neuromusc Dis 2014;1:191-5.
51. Ahdab R, Lefaucheur JP, Malapert D, et al. Neuropathy with anti-disialosyl IgM antibodies and multifocal persistent motor conduction blocks. J Neurol Neurosurg Psychiatry 2009;80:700-2.
52. Susuki K, Yuki N, Schafer DP, et al. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 2012;233:534-42.
53. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopathy and neuropathy. Lancet 1996;347:1579-82.
54. Z'Graggen WJ, Lin CS, Howard RS, et al. Nerve excitability changes in critical illness polyneuropathy. Brain 2006;129:2461-70.
55. Novak KR, Nardelli P, Cope TC, et al. Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 2009;119:1150-8.
56. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997;120:2149-57.
57. Smith KJ, Kapoor R, Hall SM, et al. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001;49:470-6.
58. Kapoor R, Davies M, Blaker PA, et al. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2003;53:174-80.
59. Alvarez S, Moldovan M, Krarup C. Acute energy restriction triggers Wallerian degeneration in mouse. Exp Neurol 2008;212:166-78.
60. McCluskey L, Feinberg D, Cantor C, et al. "Pseudo-conduction block" in vasculitic neuropathy. Muscle Nerve 1999;22:1361-6.
61. Homberg V, Reiners K, Toyka KV. Reversible conduction block in human ischemic neuropathy after ergotamine abuse. Muscle Nerve 1992;15:467-70.
62. Kaku DA, Malamut RI, Frey DJ, et al. Conduction block as an early sign of reversible injury in ischemic monomelic neuropathy. Neurology 1993;43:1126-30.
63. Magistris MR, Kohler A, Estade M. Conduction block in vasculitic neuropathy. Eur Neurol 1994;34:283-5.
64. Huynh W, Krishnan AV, Lin CS, et al. The effects of large artery ischemia and subsequent recanalization on nerve excitability. Muscle Nerve 2011;44:841-2.
65. Parry GJ, Linn DJ. Conduction block without demyelination following acute nerve infarction. J Neurol Sci 1988;84:265-73.
66. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000;123:2542-51.
67. Ohnishi A, Tsuji S, Igisu H, et al. Beriberi neuropathy. Morphometric study of sural nerve. J Neurol Sci 1980;45:177-90.
68. Ishibashi S, Yokota T, Shiojiri T, et al. Reversible acute axonal polyneuropathy associated with Wernicke-Korsakoff syndrome: impaired physiological nerve conduct ion due to thiamine deficiency? J Neurol Neurosur Psychiatry 2003;74:674-6.
69. Noguchi T, Arakawa O. Tetrodotoxin distribution and accumulation in aquatic organisms, and cases of human intoxication. Mar Drugs 2008;6:220-42.
70. Oda K, Araki K, Totoki T, et al. Nerve conduction study of human tetrodotoxication. Neurology 1989;39:743-5.
71. Uncini A, Yuki N. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes. Expert Rev Neurother 2009;9:869-84.
72. Kiernan MC, Isbister GK, Lin CS, et al. Tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005;57:339-48.
73. Franssen H, Straver DC. Pathophysiology of immune-mediated neuropathies. Part I: neuroscience. Muscle Nerve 2013;48:851-64.